PRE - IPO ANDURIL STOCK CLIMBS 50 % IN 5 MONTHS

What happened: Anduril has filed notice for a tender offer letting employees sell shares, with CNBC reporting a new private market valuation of roughly $90 billion, about 48% above its value five months earlier. Key numbers: $90 billion new valuation. $61 billion in May 2026. $30 billion earlier valuation. $4.3 billion in projected 2026 sales. $1 billion estimated annual loss. Why it matters: The article argues the valuation still looks too high, noting Anduril is losing money and may not turn a profit before 2030, and concludes the stock would likely be overpriced at IPO.

Anduril has filed notice for a tender offer letting employees sell shares, with CNBC reporting a new private market valuation of roughly $90 billion, about 48% above its value five months earlier.

The article argues the valuation still looks too high, noting Anduril is losing money and may not turn a profit before 2030, and concludes the stock would likely be overpriced at IPO.